Although these results are encouraging, the changes in the glioblastoma TIME are transient after combined IL-6 and ICI blockade, suggesting that the immunosuppressive TIME is durable and persistent despite treatment and likely necessitating a sustained treatment schedule. This evidence concerns the gene IL6 and glioblastoma.